ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 56 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $244 | +16.2% | 9,369 | +27.4% | 0.00% | 0.0% |
Q1 2024 | $210 | -80.2% | 7,355 | -78.8% | 0.00% | -90.0% |
Q4 2023 | $1,062 | -69.2% | 34,720 | -73.0% | 0.01% | -74.4% |
Q3 2023 | $3,451 | +243.0% | 128,440 | +355.4% | 0.04% | +387.5% |
Q2 2023 | $1,006 | +393.1% | 28,206 | +250.5% | 0.01% | +300.0% |
Q1 2023 | $204 | -79.6% | 8,048 | -67.4% | 0.00% | -83.3% |
Q4 2022 | $1,000 | -99.9% | 24,654 | -41.0% | 0.01% | -29.4% |
Q3 2022 | $1,382,000 | -66.7% | 41,818 | -64.6% | 0.02% | -61.4% |
Q2 2022 | $4,155,000 | -11.7% | 118,014 | +15.4% | 0.04% | +25.7% |
Q1 2022 | $4,704,000 | -45.6% | 102,293 | -21.6% | 0.04% | -25.5% |
Q4 2021 | $8,646,000 | +11.2% | 130,401 | +4.7% | 0.05% | +27.0% |
Q3 2021 | $7,775,000 | -17.6% | 124,537 | +9.3% | 0.04% | -15.9% |
Q2 2021 | $9,435,000 | +158.6% | 113,923 | +107.0% | 0.04% | +131.6% |
Q1 2021 | $3,649,000 | +22.5% | 55,033 | +41.7% | 0.02% | +18.8% |
Q4 2020 | $2,979,000 | +43.5% | 38,829 | -19.5% | 0.02% | +23.1% |
Q3 2020 | $2,076,000 | +14.7% | 48,223 | +15.1% | 0.01% | -13.3% |
Q2 2020 | $1,810,000 | +46.7% | 41,904 | -2.3% | 0.02% | +25.0% |
Q1 2020 | $1,234,000 | -6.3% | 42,883 | +106.5% | 0.01% | 0.0% |
Q4 2019 | $1,317,000 | -43.7% | 20,766 | -75.0% | 0.01% | -36.8% |
Q3 2019 | $2,339,000 | +260.4% | 83,005 | +239.1% | 0.02% | +375.0% |
Q2 2019 | $649,000 | +524.0% | 24,478 | +330.3% | 0.00% | +300.0% |
Q1 2019 | $104,000 | -37.3% | 5,688 | -57.4% | 0.00% | 0.0% |
Q4 2018 | $166,000 | +253.2% | 13,350 | +21.9% | 0.00% | – |
Q3 2017 | $47,000 | +161.1% | 10,952 | +1.3% | 0.00% | – |
Q2 2017 | $18,000 | -90.3% | 10,811 | -89.3% | 0.00% | -100.0% |
Q1 2017 | $186,000 | +365.0% | 100,747 | +287.9% | 0.00% | – |
Q4 2016 | $40,000 | -48.7% | 25,971 | +144.9% | 0.00% | -100.0% |
Q3 2016 | $78,000 | – | 10,605 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
Virtu Financial LLC | 18,008 | $78,000 | 0.00% |